ArticlePloS one2021

Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study.

Areej A Malhani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.